EXOC2

protein-coding

exocyst complex component 2, the group of IPT domain containing|Exocyst complex

Gene summary

The protein encoded by this gene is a component of the exocyst complex, a multi-protein complex essential for the polarized targeting of exocytic vesicles to specific docking sites on the plasma membrane. Though best characterized in yeast, the component proteins and the functions of the exocyst complex have been demonstrated to be highly conserved in higher eukaryotes. At least eight components of the exocyst complex, including this protein, are found to interact with the actin cytoskeletal remodeling and vesicle transport machinery. This interaction has been shown to mediate filopodia formation in fibroblasts. This protein has been shown to interact with the Ral subfamily of GTPases and thereby mediate exocytosis by tethering vesicles to the plasma membrane. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2012]

Previous symbols:
  • SEC5L1

MANE transcript

NM_018303.6

Inheritance

AR

ClinVar variants

P:1U:130B:16

Top phenotype

Neurodevelopmental disorder with dysmorphic facies and cerebellar hypoplasia

gnomAD constraint

pLI —, LoF o/e 0.42

Max pathogenic AF

—

Genomic locus

chr6:485,154-693,139

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~208.0 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

neurodevelopmental disorder with dysmorphic facies and cerebellar hypoplasiaMODERATE

Inheritance Pattern: AR

Disease ID:MONDO:0859141

Submitter: PanelApp Australia

neurodevelopmental disorder with dysmorphic facies and cerebellar hypoplasiaLIMITED

Inheritance Pattern: Unknown

Disease ID:MONDO:0859141

Submitter: Labcorp Genetics (formerly Invitae)

complex neurodevelopmental disorderLIMITED

Inheritance Pattern: AR

Disease ID:MONDO:0100038

Submitter: ClinGen

*EXOC2* was first reported in relation to autosomal recessive complex neurodevelopmental disorder in 2020 (Van Bergen et al., PMID: 32639540). Phenotypic features reported in affected individuals include developmental delay, intellectual disability, dysmorphisms, brain abnormalities, and poor motor skills. Three variants (1 nonsense and 2 missense) have been reported in the literature. One variant in *EXOC2*, reported in 2 homozygous individuals in one consanguineous family, is included in this curation (PMID: 32639540). This gene-disease relationship is also supported by rescue in patient cells and a *Drosophila* model. Defects in protein expression, global vesicle fusion rates, and cargo delivery in patient fibroblasts were restored to wild-type levels upon transduction of wild-type *EXOC2* (PMID: 32639540). Additionally, knockout of *EXOC2* expression in *Drosophila melanogaster* resulted in impairment of neuromuscular junction growth, neurite outgrowth, and vesicle trafficking to the plasma membrane (PMID: 12575951). Of note, an additional proband with compound heterozygous missense variants has been reported (PMID: 32639540). However, there is conflicting experimental functional evidence using patient cells. Out of caution, evidence for this proband and the missense variants has not been scored as additional evidence is needed to further demonstrate a relationship between these missense variants and disease. In summary, there is limited evidence to support this gene-disease relationship. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on August 1, 2023 (SOP Version 9).

Clinical Genomic Database (CGD)

Neurodevelopmental disorder with dysmorphic facies and cerebellar hypoplasiaAR

Manifestation: Craniofacial; Neurologic

Intervention: General

Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing

Refs: 32639540Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to EXOC2 variants in ClinVar

6 Conditions Cataloged
not specifiedTotal: 183
not providedTotal: 23
Neurodevelopmental disorder with dysmorphic facies and cerebellar hypoplasiaTotal: 9
EXOC2-related disorderTotal: 3
Amelogenesis imperfecta type 1FTotal: 2
Prostate cancerTotal: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_018303.6. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
5
clinvar
12
clinvar
3
clinvar
20
missense
1
clinvar
116
clinvar
1
clinvar
118
nonsense
2
clinvar
2
start loss
0
frameshift
0
splice donor/acceptor (+/-2bp)
7
clinvar
7
Total10130124147
Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 78 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_018303.6RefSeqNP_060773.327MANE Select
ENST00000230449.9EnsemblENSP00000230449.427MANE Select
ENST00000443083.5EnsemblENSP00000406400.13Standard
ENST00000870874.1EnsemblENSP00000540933.127Standard

Model Organisms & Knockout Phenotypes

Observed phenotypic effects in mouse and zebrafish models

Gene / ModelOrganismObserved Phenotype
exoc2Danio rerio

Structure: orbital region

Quality: increased accumulation

abnormal

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Ras signaling pathway - Homo sapiens (human)
  • RalA downstream regulated genes
  • Chromosomal and microsatellite instability in colorectal cancer
  • Ras Signaling
  • Arf6 trafficking events

Biological Process

  • exocytosis
  • Golgi to plasma membrane transport
  • protein transport
  • vesicle-mediated transport
  • regulation of entry of bacterium into host cell

Molecular Function

  • protein binding
  • Ral GTPase binding
  • protein kinase binding
  • protein N-terminus binding

Cellular Component

  • exocyst
  • cytosol
  • plasma membrane
  • membrane
  • Flemming body

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000230449
Coding exons
27
Length
207985
Individuals with no LoFs
125696
Homozygous LoFs
0
Heterozygous LoFs
52
Defined
125748
p
0.000207
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense1.703935000.7860.00002696071
Missense (PolyPhen)133199.520.666592374
Synonymous-0.2281941901.020.00001121709
Loss of Function4.122559.20.4220.00000306695

Population LoF Frequency

PopulationCAFp-valueStatus
African0.000120.00012rare
Latino/Admixed American0.000120.00012rare
Ashkenazi Jewish00.0absent
East Asian0.0000540.000054rare
Finnish0.000330.00032rare
European (Non-Finnish)0.000270.00027rare
South Asian0.000160.00016rare
Other0.000330.00033rare

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Component of the exocyst complex involved in the docking of exocytic vesicles with fusion sites on the plasma membrane.;

Recessive Scores

pRec
0.153

Intolerance Scores

LoFtool
0.754
RVIS EVS
-0.97
RVIS percentile EVS
8.9

Essentials

Essential (CRISPR)
E
Essential (CRISPR2)
S
Essential (gene trap)
E
Indispensability pred.
E
Indispensability score
0.959

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.